Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2010

View Archived Issues

Aldosterone synthase inhibitor LCI-699 shows promise in hypertension trial

Reduced risk for stroke and embolism with dabigatran compared to warfarin in RE-LY trial

Unfavorable risk-benefit noted with anticoagulant/antiplatelet therapy in atrial fibrillation

NeuroSearch claims nicotinic acetylcholine alpha7 receptor ligands and monoamine receptor modulators

Probiodrug discloses novel glutaminyl cyclase inhibitors

New SCD-1 inhibitors discovered by sanofi-aventis

Biolipox presents new leukotriene C4 synthase inhibitors

Auckland Uniservices discovers novel nitrobenzindole prodrugs for treatment of cancer

Merck & Co. selects antiobesity CB1 inverse agonist MK-5596 as clinical candidate

Regadenoson in myocardial perfusion imaging exhibits safety in heart transplant patients

Pfizer discloses identification of selective PDE9 inhibitors at ACS meeting

FDA allows GeoVax to start phase I clinical trial of HIV vaccine

NeurOp and Bristol-Myers Squibb enter drug discovery collaboration

Stem Cell Therapeutics completes enrollment in phase IIb REGENESIS stroke trial

QRxPharma begins phase I trial of CR morphine/oxycodone for chronic pain

ViroPharma begins phase II Cinryze trial in pediatric HAE patients

VIA Pharmaceuticals reports strategic restructuring and R&D pipeline update

GSK's Duodart approved for benign prostatic hyperplasia in E.U.

Ardea reports phase IIb RDEA-594 monotherapy data in hyperuricemia and gout

Orexigen submits NDA in U.S. for Contrave obesity treatment

GSK and Isis to develop RNA-targeted therapeutics for rare and infectious diseases

AMAG and Takeda enter into agreement to develop and market Feraheme

ArQule reports phase II data on ARQ-197 in non-small cell lung cancer

Phase II data reported for OMS-103-HP in arthroscopic meniscectomy surgery

Symphogen begins phase I/II Sym-004 trial in advanced solid tumors

Alzheimer's Drug Discovery Foundation funds Signum Biosciences' research

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...